Literature DB >> 1909569

Mechanism of DNA polymerase alpha inhibition by aphidicolin.

R Sheaff1, D Ilsley, R Kuchta.   

Abstract

Synthetic oligonucleotides of defined sequence were used to examine the mechanism of calf thymus DNA polymerase alpha inhibition by aphidicolin. Aphidicolin competes with each of the four dNTPs for binding to a pol alpha-DNA binary complex and thus should not be viewed as a dCTP analogue. Kinetic evidence shows that inhibition proceeds through the formation of a pol alpha.DNA.aphidicolin ternary complex, while DNase I protection experiments provide direct physical evidence. When deoxyguanosine is the next base to be replicated, Ki = 0.2 microM. In contrast, the Ki is 10-fold higher when the other dNMPs are at this position. Formation of a pol alpha.DNA.aphidicolin ternary complex did not inhibit the primase activity of the pol alpha.primase complex. Neither the rate of primer synthesis nor the size distribution of primers 2-10 nucleotides long was changed. Elongation of the primase-synthesized primers by pol alpha was inhibited both by ternary complex formation using exogenously added DNA and by aphidicolin alone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909569     DOI: 10.1021/bi00099a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Vertebrate HoxB gene expression requires DNA replication.

Authors:  Daniel Fisher; Marcel Méchali
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

2.  Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint.

Authors:  Tony S Byun; Marcin Pacek; Muh-ching Yee; Johannes C Walter; Karlene A Cimprich
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

3.  Bloom's syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress.

Authors:  Tsutomu Shimura; Michael J Torres; Melvenia M Martin; V Ashutosh Rao; Yves Pommier; Mari Katsura; Kiyoshi Miyagawa; Mirit I Aladjem
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

4.  Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells.

Authors:  Mangmang Li; Yunlong He; Wendy Dubois; Xiaolin Wu; Jianxin Shi; Jing Huang
Journal:  Mol Cell       Date:  2012-03-01       Impact factor: 17.970

5.  DNA polymerase-β mediates the neurogenic effect of β-amyloid protein in cultured subventricular zone neurospheres.

Authors:  Marco Calafiore; Agata Copani; Wenbin Deng
Journal:  J Neurosci Res       Date:  2011-11-04       Impact factor: 4.164

6.  A novel assay revealed that ribonucleotide reductase is functionally important for interstrand DNA crosslink repair.

Authors:  Naoaki Fujii; Benjamin J Evison; Marcelo L Actis; Akira Inoue
Journal:  Bioorg Med Chem       Date:  2015-09-30       Impact factor: 3.641

7.  Interactions of calf thymus DNA polymerase alpha with primer/templates.

Authors:  H C Thompson; R J Sheaff; R D Kuchta
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

8.  Generation of single-nucleotide repair patches following excision of uracil residues from DNA.

Authors:  G Dianov; A Price; T Lindahl
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

9.  Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs.

Authors:  M Alaoui-Jamali; B B Loubaba; S Robyn; H Tapiero; G Batist
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication.

Authors:  Tsutomu Shimura; Melvenia M Martin; Michael J Torres; Cory Gu; Janice M Pluth; Maria A DeBernardi; Maria A DiBernardi; Jeffrey S McDonald; Mirit I Aladjem
Journal:  J Mol Biol       Date:  2007-01-12       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.